Literature DB >> 9316939

Evaluation of the AMPLICOR CMV test for direct detection of cytomegalovirus in plasma specimens.

M Hiyoshi1, S Tagawa, T Takubo, K Tanaka, T Nakao, Y Higeno, K Tamura, M Shimaoka, A Fujii, M Higashihata, Y Yasui, T Kim, A Hiraoka, N Tatsumi.   

Abstract

We evaluated the AMPLICOR CMV test (PCR) for the direct detection of cytomegalovirus in plasma. Sixty-eight specimens were involved for the comparison between the AMPLICOR test and the antigenemia assay. The sensitivities, specificities, and positive and negative predictive values were 97.1, 100, 100, and 97.1%, respectively, for the AMPLICOR test and 79.4, 100, 100, and 82.9%, respectively, for the antigenemia assay.

Mesh：

Substances：

Year:  1997        PMID： 9316939      PMCID： PMC230042          DOI： 10.1128/jcm.35.10.2692-2694.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

Review 1.  Cytomegalovirus antigenemia.

Authors:  T H The; W van der Bij; A P van den Berg; M van der Giessen; J Weits; H G Sprenger; W J van Son
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

2.  Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence.

Authors:  M L Landry; D Ferguson; T Stevens-Ayers; M W de Jonge; M Boeckh
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Cytomegalovirus DNA in the sera of patients with cytomegalovirus pneumonia.

Authors:  S Ishigaki; M Takeda; T Kura; N Ban; T Saitoh; S Sakamaki; N Watanabe; Y Kohgo; Y Niitsu
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

4.  Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification.

Authors:  S A Spector; R Merrill; D Wolf; W M Dankner
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

5.  Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections.

Authors:  M Brytting; W Xu; B Wahren; V A Sundqvist
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

6.  Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation.

Authors:  H Gondo; T Minematsu; M Harada; K Akashi; S Hayashi; S Taniguchi; K Yamasaki; T Shibuya; Y Takamatsu; T Teshima
Journal:  Br J Haematol       Date:  1994-01       Impact factor: 6.998

7.  Comparison between viremia and antigenemia for detection of cytomegalovirus in blood.

Authors:  W van der Bij; J Schirm; R Torensma; W J van Son; A M Tegzess; T H The
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

8.  Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes.

Authors:  D Zipeto; S Morris; C Hong; A Dowling; R Wolitz; T C Merigan; L Rasmussen
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

9.  Detection of cytomegalovirus DNA in sera of liver transplant recipients.

Authors:  R Patel; T F Smith; M Espy; R H Wiesner; R A Krom; D Portela; C V Paya
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

10.  Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection.

Authors:  F Freymuth; E Gennetay; J Petitjean; G Eugene; B Hurault de Ligny; J P Ryckelynck; C Legoff; P Hazera; C Bazin
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948
View more
  16 in total

1.  Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation.

Authors:  A Weinberg; T N Hodges; S Li; G Cai; M R Zamora
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.

Authors:  R R Razonable; R A Brown; M J Espy; A Rivero; W Kremers; J Wilson; C Groettum; T F Smith; C V Paya
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Evaluation of a new automated, standardized generic nucleic acid extraction method (total nucleic acid isolation kit) used in combination with cytomegalovirus DNA quantification by COBAS AMPLICOR CMV MONITOR.

Authors:  Barbara Christine Gärtner; Johannes Michael Fischinger; Anke Litwicki; Klaus Roemer; Nikolaus Mueller-Lantzsch
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects.

Authors:  G Boivin; J Handfield; E Toma; G Murray; R Lalonde; V J Tevere; R Sun; M G Bergeron
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Detection of cytomegalovirus in plasma and cerebrospinal fluid specimens from human immunodeficiency virus-infected patients by the AMPLICOR CMV test.

Authors:  C M Long; L Drew; R Miner; D Jekic-McMullen; C Impraim; S Y Kao
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 6.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 7.  Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants.

Authors:  Ellen Meijer; Greet J Boland; Leo F Verdonck
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients.

Authors:  W Y Barrett-Muir; C Aitken; K Templeton; M Raftery; S M Kelsey; J Breuer
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.

Authors:  C Y Tong; L Cuevas; H Williams; A Bakran
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients.

Authors:  Heli Piiparinen; Krister Höckerstedt; Maija Lappalainen; Jukka Suni; Irmeli Lautenschlager
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.